KR950700726A - 치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use) - Google Patents
치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use)Info
- Publication number
- KR950700726A KR950700726A KR1019940703558A KR19940703558A KR950700726A KR 950700726 A KR950700726 A KR 950700726A KR 1019940703558 A KR1019940703558 A KR 1019940703558A KR 19940703558 A KR19940703558 A KR 19940703558A KR 950700726 A KR950700726 A KR 950700726A
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- diagnosis
- therapeutic
- preparation
- manufacturing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6917—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a lipoprotein vesicle, e.g. HDL or LDL proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86525692A | 1992-04-08 | 1992-04-08 | |
| PCT/FI1993/000149 WO1993020800A1 (en) | 1992-04-08 | 1993-04-07 | Composition for therapeutic or diagnostic use, process for its preparation and its use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR950700726A true KR950700726A (ko) | 1995-02-20 |
Family
ID=25345059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019940703558A KR950700726A (ko) | 1992-04-08 | 1994-10-07 | 치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use) |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0634926A1 (ko) |
| JP (1) | JPH07505408A (ko) |
| KR (1) | KR950700726A (ko) |
| AU (1) | AU3892593A (ko) |
| CA (1) | CA2117749A1 (ko) |
| WO (1) | WO1993020800A1 (ko) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102387248B1 (ko) | 2021-07-06 | 2022-04-15 | (주)효림세울 | 난연 사이로필 방적사 제조 설비 및 이를 사용하여 제조된 난연 사이로필 방적사 및 난연 사이로필 방적사 제조 방법 |
| KR20230145752A (ko) | 2022-04-11 | 2023-10-18 | (주)효림세울 | 몰토 자스페 원사 제조설비 및 이를 사용한 몰토 자스페 원사 제조 방법 |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995013096A1 (en) * | 1993-11-08 | 1995-05-18 | Peptide Delivery Systems Pty. Ltd. | Labelled diagnostic compositions and methods of their use |
| DE19500665A1 (de) * | 1995-01-12 | 1996-07-18 | Axel Prof Dr Haase | Verfahren zur ortsauflösenden Abbildung eines Bereiches eines biologischen Objektes mit Hilfe elektromagnetischer Strahlen unter Applikation von Kontrastmittel |
| GB2321455A (en) | 1997-01-24 | 1998-07-29 | Norsk Hydro As | Lipophilic derivatives of biologically active compounds |
| US5827533A (en) * | 1997-02-06 | 1998-10-27 | Duke University | Liposomes containing active agents aggregated with lipid surfactants |
| JP2005515452A (ja) | 2001-10-24 | 2005-05-26 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | アイソトープで標識された水を用いるヒトおよび実験系におけるタンパク質合成速度の測定 |
| CA2475924C (en) | 2002-02-12 | 2016-03-29 | The Regents Of The University Of California | Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation |
| EP1546364A4 (en) | 2002-07-30 | 2006-09-06 | Univ California | METHOD FOR THE LARGE-SCALE AUTOMATIC MEASUREMENT OF PROTEOMIC OR ORGANOMOMIC MOLECULAR FLOW RATES BY MASS SPECTROMETRY |
| CA2498378C (en) * | 2002-09-13 | 2013-12-17 | The Regents Of The University Of California | Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis |
| AU2003291731B2 (en) | 2002-11-04 | 2009-09-10 | The Regents Of The University Of California | Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body |
| US7262020B2 (en) | 2003-07-03 | 2007-08-28 | The Regents Of The University Of California | Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
| US20050202406A1 (en) | 2003-11-25 | 2005-09-15 | The Regents Of The University Of California | Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems |
| TW200538738A (en) | 2004-02-20 | 2005-12-01 | Univ California | Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity |
| JP2014526685A (ja) | 2011-09-08 | 2014-10-06 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | 代謝流量測定、画像化、および顕微鏡法 |
| ES2668678T3 (es) | 2011-12-07 | 2018-05-21 | Glaxosmithkline Llc | Procedimiento de determinación de la masa muscular esquelética corporal total |
| US9134319B2 (en) | 2013-03-15 | 2015-09-15 | The Regents Of The University Of California | Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE456136B (sv) * | 1985-06-17 | 1988-09-12 | Oncholab Ab | Forfarande for framstellning av en med ett lipofilt biologiskt aktivt emne bemengd berare pa basis av rekonstituerat ldl (lagdensitetslipoprotein) |
-
1993
- 1993-04-07 AU AU38925/93A patent/AU3892593A/en not_active Abandoned
- 1993-04-07 WO PCT/FI1993/000149 patent/WO1993020800A1/en not_active Application Discontinuation
- 1993-04-07 CA CA002117749A patent/CA2117749A1/en not_active Abandoned
- 1993-04-07 JP JP5518017A patent/JPH07505408A/ja active Pending
- 1993-04-07 EP EP93907890A patent/EP0634926A1/en not_active Withdrawn
-
1994
- 1994-10-07 KR KR1019940703558A patent/KR950700726A/ko not_active Application Discontinuation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102387248B1 (ko) | 2021-07-06 | 2022-04-15 | (주)효림세울 | 난연 사이로필 방적사 제조 설비 및 이를 사용하여 제조된 난연 사이로필 방적사 및 난연 사이로필 방적사 제조 방법 |
| KR20230145752A (ko) | 2022-04-11 | 2023-10-18 | (주)효림세울 | 몰토 자스페 원사 제조설비 및 이를 사용한 몰토 자스페 원사 제조 방법 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993020800A1 (en) | 1993-10-28 |
| EP0634926A1 (en) | 1995-01-25 |
| JPH07505408A (ja) | 1995-06-15 |
| AU3892593A (en) | 1993-11-18 |
| CA2117749A1 (en) | 1993-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950700726A (ko) | 치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use) | |
| KR0125921B1 (en) | Method and device for the diagnosis and treatment of nasal diseases | |
| US5443960B1 (en) | Method for the diagnosis of blood coagulation disorders | |
| ATE29729T1 (de) | Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus. | |
| CA2189658A1 (en) | Controlled-Release Dosage Forms of Azithromycin | |
| BG95935A (bg) | Метод и средство за приемане на дексмедетомидин директно през кожата | |
| CY2007001I2 (el) | Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη | |
| DE3764253D1 (de) | Medizinischer saugkoerper mit roentgenkontrastmittel und verfahren zu seiner herstellung. | |
| BR9503812A (pt) | Composto composição farmacêutica utilização método de tratamento de um ser humano processo para a preparação de um composto | |
| DE58908452D1 (de) | Medizinisches Gerät zur Diagnose und/oder Therapie. | |
| EP0771788A3 (de) | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament | |
| AU581850B2 (en) | A compound and a composition for therapeutic or diagnostic use and a method for therapeutic treatment | |
| IL81370A (en) | Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions | |
| DE3248943D2 (en) | Method for the diagnostic and the therapeutic treatment of tumors and/or infectious diseases of all sorts by the use of alkaloid compositions or the salts thereof | |
| HRP970292A2 (en) | Substituted 2-naphtoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicament containing them | |
| AU3861989A (en) | Method for the treatment and the diagnosis of coronary heart disease | |
| CY2220B1 (en) | Substituted benzenesulfonylureas and -thioureas process for their preparation their use as medicament or diagnostic agent as well as medicaments containing them | |
| PL309386A1 (en) | Ortho-amino-substituted benzoyl guanidines, method of obtaining them their application as therapeutric or diagnostic agents and therapeutic agent containing them | |
| NO880292D0 (no) | Fremgangsmaate for behandling av humle. | |
| AU8204182A (en) | Apparatus for the medical treatment of living organisms, particularly human beings | |
| HRP970424B1 (en) | Substituted indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic agents and medicaments containing them | |
| HRP970294A2 (en) | Substituted 1-naphtoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicaments containing them | |
| EP0436717A4 (en) | Method of treatment with medical agents | |
| IL93826A0 (en) | New method for the diagnosis of virulent bacteria | |
| GR3032293T3 (en) | Ortho-substituted benzylguanidines, process for their preparation and their use as medicament or diagnostic agent as well as medicament containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |